-+ 0.00%
-+ 0.00%
-+ 0.00%

Alto Neuroscience Q2 EPS $(0.65) Misses $(0.61) Estimate

Benzinga·08/13/2025 20:25:37
Listen to the news
Alto Neuroscience (NYSE:ANRO) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.61) by 7.08 percent. This is a 8.33 percent decrease over losses of $(0.60) per share from the same period last year.